87 related articles for article (PubMed ID: 21457483)
1. Glucosamine inhibits epithelial-to-mesenchymal transition and migration of retinal pigment epithelium cells in culture and morphologic changes in a mouse model of proliferative vitreoretinopathy.
Liang CM; Tai MC; Chang YH; Chen YH; Chen CL; Lu DW; Chen JT
Acta Ophthalmol; 2011 Sep; 89(6):e505-14. PubMed ID: 21457483
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein 6 (BMP6) antagonises experimental proliferative vitreoretinopathy established by TGF-β2 stimulation in retinal pigment epithelial cells through modulation of the p38 and JNK MAPK pathways.
Liu X; Liu M; Chen L
Cell Tissue Res; 2024 Apr; 396(1):103-117. PubMed ID: 38403744
[TBL] [Abstract][Full Text] [Related]
3. Targeting non-muscle myosin II inhibits proliferative vitreoretinopathy through regulating epithelial-mesenchymal transition.
Jiang H; Chen Y; He Z; Li J; Gao Q; Li W; Wei W; Zhang Y
Biochem Biophys Res Commun; 2023 Dec; 686():149149. PubMed ID: 37918204
[TBL] [Abstract][Full Text] [Related]
4. Ligand-independent activation of platelet-derived growth factor receptor β promotes vitreous-induced contraction of retinal pigment epithelial cells.
Duan Y; Wu W; Cui J; Matsubara JA; Kazlauskas A; Ma G; Li X; Lei H
BMC Ophthalmol; 2023 Aug; 23(1):344. PubMed ID: 37537538
[TBL] [Abstract][Full Text] [Related]
5. TNF-α and NF-κB signaling play a critical role in cigarette smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy.
Wang V; Heffer A; Roztocil E; Feldon SE; Libby RT; Woeller CF; Kuriyan AE
PLoS One; 2022; 17(9):e0271950. PubMed ID: 36048826
[TBL] [Abstract][Full Text] [Related]
6. IKKβ Inhibition Attenuates Epithelial Mesenchymal Transition of Human Stem Cell-Derived Retinal Pigment Epithelium.
Sripathi SR; Hu MW; Turaga RC; Mikeasky R; Satyanarayana G; Cheng J; Duan Y; Maruotti J; Wahlin KJ; Berlinicke CA; Qian J; Esumi N; Zack DJ
Cells; 2023 Apr; 12(8):. PubMed ID: 37190063
[TBL] [Abstract][Full Text] [Related]
7. Silibinin Prevents TGFβ-Induced EMT of RPE in Proliferative Vitreoretinopathy by Inhibiting Stat3 and Smad3 Phosphorylation.
Ma X; Xie Y; Gong Y; Hu C; Qiu K; Yang Y; Shen H; Zhou X; Long C; Lin X
Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):47. PubMed ID: 37906058
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein-6 suppresses TGF-β
Liu X; Liu M; Ji M; Ma B; Hou YC; Yao XY; Cheng QC; Chen L
Int J Ophthalmol; 2024; 17(4):646-652. PubMed ID: 38638261
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal Transition (EMT) and the Effect of Atorvastatin on it in ARPE-19 cells.
Mysore Y; Hytti M; Deen AJ; Ranta-Aho S; Piippo N; Toppila M; Loukovaara S; Harju N; Kauppinen A
Cell Biochem Biophys; 2024 May; ():. PubMed ID: 38777991
[TBL] [Abstract][Full Text] [Related]
10. A brief review of the histopathology of proliferative vitreoretinopathy (PVR).
Mudhar HS
Eye (Lond); 2020 Feb; 34(2):246-250. PubMed ID: 31792351
[TBL] [Abstract][Full Text] [Related]
11. Epithelial membrane protein-2 (EMP2) and experimental proliferative vitreoretinopathy (PVR).
Telander DG; Morales SA; Mareninov S; Forward K; Gordon LK
Curr Eye Res; 2011 Jun; 36(6):546-52. PubMed ID: 21591864
[TBL] [Abstract][Full Text] [Related]
12. Expression of PDGFRα is a determinant of the PVR potential of ARPE19 cells.
Lei H; Rhéaume MA; Velez G; Mukai S; Kazlauskas A
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):5016-21. PubMed ID: 21642621
[TBL] [Abstract][Full Text] [Related]
13. Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model.
Heffer AM; Wang V; Libby RT; Feldon SE; Woeller CF; Kuriyan AE
PLoS One; 2020; 15(12):e0243626. PubMed ID: 33347461
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of TGF-β2-induced migration and epithelial-mesenchymal transition in ARPE-19 by sulforaphane.
Huang YB; Liu PP; Zheng H; Yang XX; Yang CC; Liu Y; Liu Y
Int J Ophthalmol; 2021; 14(7):973-980. PubMed ID: 34282380
[TBL] [Abstract][Full Text] [Related]
15. Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathy.
Delgado-Tirado S; Amarnani D; Zhao G; Rossin EJ; Eliott D; Miller JB; Greene WA; Ramos L; Arevalo-Alquichire S; Leyton-Cifuentes D; Gonzalez-Buendia L; Isaacs-Bernal D; Whitmore HAB; Chmielewska N; Duffy BV; Kim E; Wang HC; Ruiz-Moreno JM; Kim LA; Arboleda-Velasquez JF
Sci Rep; 2020 Nov; 10(1):20554. PubMed ID: 33257736
[TBL] [Abstract][Full Text] [Related]
16. FAK activation and the role of epithelial membrane protein 2 (EMP2) in collagen gel contraction.
Morales SA; Mareninov S; Wadehra M; Zhang L; Goodglick L; Braun J; Gordon LK
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):462-9. PubMed ID: 18469192
[TBL] [Abstract][Full Text] [Related]
17. Mechanism underlying Müller cell pyroptosis and its role in the development of proliferative vitreoretinopathy.
Bai Y; Xie M; Zhu Y
Clinics (Sao Paulo); 2023; 78():100241. PubMed ID: 37418795
[TBL] [Abstract][Full Text] [Related]
18. The tight junction associated signalling proteins ZO-1 and ZONAB regulate retinal pigment epithelium homeostasis in mice.
Georgiadis A; Tschernutter M; Bainbridge JW; Balaggan KS; Mowat F; West EL; Munro PM; Thrasher AJ; Matter K; Balda MS; Ali RR
PLoS One; 2010 Dec; 5(12):e15730. PubMed ID: 21209887
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of ASPP2 expression alleviates the development of proliferative vitreoretinopathy in a rat model.
Yue YK; Chen XL; Liu S; Liu W
Int J Ophthalmol; 2021; 14(12):1813-1819. PubMed ID: 34926193
[TBL] [Abstract][Full Text] [Related]
20. Tricetin suppresses the cell migration and BMP-6 expression through p38 signaling pathways in human retinal pigment epithelium cells.
Chien HW; Chuang CC; Hsieh YH; Lee CY; Yu NY; Yang SF
Environ Toxicol; 2024 Apr; ():. PubMed ID: 38654487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
